SCHEMBL3379650

SCHEMBL3379650

CC1(C)OC(=O)Nc2ccc(C=O)cc21

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PGR P06401 20/20 0.56
AR P10275 4/20 0.51
NR3C1 P04150 3/20 0.51
NR3C2 P08235 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127120 0.80 PGR (0.53) PGRARNR3C1NR3C2
SCHEMBL4132340 0.80 PGR (0.53) PGRARNR3C1NR3C2
SCHEMBL4134946 0.80 PGR (0.49) PGRARNR3C1NR3C2
SCHEMBL4129799 0.80 PGR (0.49) PGRARNR3C1NR3C2
SCHEMBL4129797 0.80 PGR (0.49) PGRARNR3C1NR3C2
SCHEMBL4127125 0.80 PGR (0.53) PGRARNR3C1NR3C2
SCHEMBL4130623 0.79 PGR (0.48) PGRARNR3C1NR3C2
SCHEMBL4111764 0.79 PGR (0.48) PGRARNR3C1NR3C2
SCHEMBL4111758 0.79 PGR (0.48) PGRARNR3C1NR3C2
SCHEMBL4118910 0.79 PGR (0.48) PGRARNR3C1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-06-24 US disclosed
EP-1844768-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160304-A1 AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR NR3C2, AGTR1, AGTR2 PGR 288/4885AR 17/4885NR3C1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.